Prevention of kidney arteriosclerosis: heparin, dipyridamole, warfarin, and plasma exchange.
Kincaid-Smith
P
P
D001161:Arteriosclerosis / Q000209:etiology / Q000517:prevention & control*; D001706:Biopsy; D004176:Dipyridamole / Q000627:therapeutic use*; D006084:Graft Rejection; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007668:Kidney / Q000098:blood supply / Q000473:pathology; D007678:Kidney Glomerulus / Q000473:pathology; D016030:Kidney Transplantation; D010951:Plasma Exchange; D011446:Prospective Studies; D013997:Time Factors; D014859:Warfarin / Q000627:therapeutic use*
D014859:Warfarin; D004176:Dipyridamole; D006493:Heparin